UNIVERSITY OF SOUTH CAROLINA Department of Computer Science and Engineering A Causal Probabilitic Network for Optimal Treatment of Bachterial Infections.

Slides:



Advertisements
Similar presentations
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Advertisements

DIAGNOSTICS: LIFE PRESERVERS FOR PEOPLE AND ANTIBIOTICS Barry Eisenstein, MD Senior Vice President, Scientific Affairs Cubist Pharmaceuticals.
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
MODELING THE PROGRESSION AND TREATMENT OF HIV Presented by Dwain John, CS Department, Midwestern State University Steven M. Shechter Andrew J. Schaefer.
1 Acute Cough Definitions of Lower Respiratory Tract Infections (LRTI), ranging in severity: Acute bronchitis - an acute respiratory tract infection in.
Save Antibiotic Strength Health Plans Address the Challenge of Antibiotic Resistance Robert Scalettar, M.D. July 19, 2005.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
TREAT -a Decision Support System for Antibiotic Treatment Supported by an EU 5 th Framework grant Coordinator: Steen Andreassen On behalf of the Treat.
Pathogenic Bacteriology Introduction. What the class will cover: Clinically significant bacteria Morphological characteristics Biochemical characteristics.
Improvements in the Spatial and Temporal representation of the Model Owen Woodberry Bachelor of Computer Science, Honours.
27/9/2010Definitions in Epidemiology (Dr. Salwa Tayel) 1.
TREAT – A Decision Support System for Antibiotic Treatment S. Andreassen 1, L.E Kristensen 2, L. Leibovici 3, U. Frank 4, J. H. Jensen 1, H. C. Schønheyder.
Simplification Tactics Dr. Saeed Shiry Amirkabir University of Technology Computer Engineering & Information Technology Department.
How Science Works Glossary AS Level. Accuracy An accurate measurement is one which is close to the true value.
PHL 424 Antimicrobials 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
PHL 521 Clinical Dental Therapeutics 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
Office of Drug Evaluation IV, CDER FDA/IDSA/ISAP Workshop 4/16/04 Overview of PK-PD in Drug Development Programs: FDA Perspective FDA/IDSA/ISAP Workshop.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
Primary Care Research in Northern Ireland: where’s the evidence? Carmel M. Hughes School of Pharmacy Queen’s University Belfast.
Antibiotic overuse and misuse in long term care Shira Doron, MD Assistant Professor of Medicine Division of Geographic Medicine and Infectious Diseases.
THE COMMONWEALTH FUND Exhibit 1. Availability of Public Information “In your view, how important do you think it is to have information about each of the.
Design of Clinical Trials of Antibiotic Therapy for Acute Otitis Media
Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 1 Improvement in Dose Selection: FDA Perspective IDSA/ISAP/FDA Workshop.
July 2015 PRABHAVATHI FERNANDES, PhD Founder, President and CEO How the PATH Act Can Rejuvenate Antibiotic R & D.
 Definitions  Goals of automation in pharmacy  Advantages/disadvantages of automation  Application of automation to the medication use process  Clinical.
Smart use of antibiotics: building confidence in new approaches Dr. Hayley Wickens.
Real-time control Model-Based Blood Glucose Control for Neonatal Intensive Care Engineering robust solutions for our most fragile infants Background and.
Neonates (children less than one month of age) have immature immune systems and are at higher risk for serious complications of bacterial and viral infections,
PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.
Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support health professionals caring for people living with MCC.
Sexually Transmitted Infection (STI): Any pathogen that spreads from one person to another during sexual contact.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 7 Penicillins.
Bacteremia and CRBSI as Labeled BSI Indications: A Regulatory History Alfred Sorbello, DO Medical Officer CDER/Division of Anti-Infective Drug Products.
Cambodia1. 2 Cambodia Assessment Ung Phirun Chroeng Sokhan.
Clinical Research Networks Notifications Practice Policy Stewardship Lives Saved Diagnostics Pathogenesis Incidence Outcome Risk Factors Treatment Public.
Decision Analysis Dr M G Dawes Centre for Evidence Based Medicine.
Approach To Pneumonia. Pneumonia Importance Mechanism Classification & its benefit Diagnosis Treatment.
Simulation is the process of studying the behavior of a real system by using a model that replicates the behavior of the system under different scenarios.
Antibiotics Broad Spectrum vs Narrow Spectrum. Two Groups of antibiotics An antibiotic may be classified basically as "narrow- spectrum" or "broad-spectrum"
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Variation in Outpatient Antibiotic use for Acute Respiratory Infections in the Veteran Population. Final Figures 1, 2, 3, 4, 5, 6.
DENS 521 Clinical Dental Therapeutics 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
1 1 Slide Simulation Professor Ahmadi. 2 2 Slide Simulation Chapter Outline n Computer Simulation n Simulation Modeling n Random Variables and Pseudo-Random.
Alcohol and AIDS: A New Decade Grantsmanship Workshop XIX International AIDS Conference Rome, Italy Kendall J. Bryant, Ph.D., NIAAA Alcohol and AIDS Research.
Expanding Regulated Private Sector Medicines Access - Experiences with Accredited Drug Dispensing Outlets Romuald Mbwasi, PhD.
STAKEHOLDERANALYSIS Boot Camp WHY CARE ABOUT STAKEHOLDERS? Where are we? (most of you)  Identified Need; Developed Concept / Solution What do we.
Antibiotics I.. Consequences of inappropriate antibiotic therapy Inappropriate antibiotic therapy can lead to increases in:Inappropriate antibiotic therapy.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Chapter Legislative Representatives Government Affairs Update April 2014.
1 Midterm Issues. 2 Social Context Social context is a specific role that a person has in society –E.g. Doctor, lawyer, patient, voter –Not an issue of.
Acute Bacterial Otitis Media Summary and Charge to the Committee Renata Albrecht, M.D. Division of Special Pathogen and Immunologic Drug Products ODEIV,
NHMRC Clinical Trials Centre ANZGOG AGM, 2 April 2009, Noosa NHMRC Clinical Trials Centre Symptom Benefit Study Measuring the Benefit of Palliative Chemotherapy.
Phage therapy for the treatment for urinary tract infection: Results of in-vitro screenings and in-vivo application using commercially available bacteriophage.
Depart. Of Pulmonology and Critical Care Medicine R4 백승숙.
Outcomes of Carbapenem-Resistant K. pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies Gopi Patel, MD; Shirish Huprikar, MD;
Copyright © 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. Musculoskeletal Disorders.
Nosocomial Antibiotic Resistant Organisms
ANTI-MICROBIAL USAGE IN THE COMMUNITY AND RESISTANCE IN E.COLI
Figure 1. Rate of antimicrobial resistance in S. pneumoniae
Professor Alan Johnson Department of HCAI & AMR
Ashry Gad Mohamed Prof. of Epidemiology
Hospital Antibiotic Stewardship Programs
The Research Question In non-asthmatic adults presenting to primary care with acute lower respiratory tract infection and not requiring immediate antibiotics.
MRSA=Methicillin resistant Staphylococcus aureus
A Time for Change for Managing Patients With VTE Who Have Cancer
Unit 2- Population, Health, and Migration
Unit 2- Population, Health, and Migration
Hospital pharmacy.
Mar Pujades-Rodriguez, Robert M. West, Mark H. Wilcox, Jonathan Sandoe
Presentation transcript:

UNIVERSITY OF SOUTH CAROLINA Department of Computer Science and Engineering A Causal Probabilitic Network for Optimal Treatment of Bachterial Infections Alicia Ruvinsky Scott Langevin

UNIVERSITY OF SOUTH CAROLINA Department of Computer Science and Engineering Problem: Bacterial Infections 30 percent mortality rate from severe bacterial infection 1/3 given inappropriate treatment 20% prescribed superfluous drugs Anti-biotic drugs account for percent of hospitals drug expenses Bacterial resistance to anti-biotic treatment aggravated by miss-diagnoses

UNIVERSITY OF SOUTH CAROLINA Department of Computer Science and Engineering Research Objectives Build a Decision Support System to provide: Likelihood of a bacterial infection Measure of its severity Most likely site of infection Most likely pathogen Susceptibility of pathogen to drugs Gain in life expectancy through treatment Cost of drug treatment (price, side-effect, ecological impact, future resistance) Ranking of anti-biotic drugs (Cost-Benefit)

UNIVERSITY OF SOUTH CAROLINA Department of Computer Science and Engineering Problems with initial BN Approach Model is not portable (specific to region/hospital) –Dichotomous data (local vs universal) Human input error (20% of cases) Obviating Enhancements Fix by normalizing system (localizing model) Fix by objective input requirements (symptoms, test results, etc)

UNIVERSITY OF SOUTH CAROLINA Department of Computer Science and Engineering General Modularized Design Nodes in BN: Pathogen - Represent the potential pathogens of infections at the given site M_Distrib – Major patient-groups exhibiting a particular pathogen within the given site Minor – minor distribution factors; factors that change the likelihood of one or more pathogens without affecting the overall risk for infection. Infection – the different patterns in which infections manifest Local-respo – local responses caused by an infection Local-sign – manifestation of local responses. Sys-respo – systemic response caused by infection and common to all sites of infections Sign – manifestations of sys-respo Spec-cultu – ability of pathogen to grow in local specimen Blood-cultu – ability of pathogen to grow in the blood Lab-site – ability of pathogen to grow at local site Antibiotic_tr – antibiotic treatment prescribed for an infection Coverage – the percentage of pathogens of a given infection susceptible to an antibiotic drug Resistance – in-vitro susceptibility of pathogen to treatment Cost – accounts for cost of using antibiotic: cost of purchase, side effects, and ecological impact Gain – net gain in life expectancy gotten by prescribing an antibiotic drug Underlying – disorders of the patient

UNIVERSITY OF SOUTH CAROLINA Department of Computer Science and Engineering General Scheme for Site of Infection Network

UNIVERSITY OF SOUTH CAROLINA Department of Computer Science and Engineering Urinary Tract Infections Network

UNIVERSITY OF SOUTH CAROLINA Department of Computer Science and Engineering Calibrating the System

UNIVERSITY OF SOUTH CAROLINA Department of Computer Science and Engineering Results Addresses all important decision-points in first days of patient care Expect the system to perform better than clinician No test data showing it improves clinical practice and patient outcome - need a clinical trial Convenience of calibrating system for new locations?